HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis
Cell death: Blocking the self-destruct mechanism Researchers have identified a compound that inhibits necroptosis, a type of programmed cell death that occurs naturally but that can be harmful when overactivated. Necroptosis helps defend against disease, triggering virus-infected cells to self-destr...
Main Authors: | Han-Hee Park, Se-Yeon Park, Shinmee Mah, Jung-Hee Park, Soon-Sun Hong, Sungwoo Hong, You-Sun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-09-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-018-0152-8 |
Similar Items
-
Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury
by: Shelly A Cruz, et al.
Published: (2018-01-01) -
Cisplatin-Induced Ototoxicity in Rats Is Driven by RIP3-Dependent Necroptosis
by: Mi-Jin Choi, et al.
Published: (2019-05-01) -
ICP6 Prevents RIP1 Activation to Hinder Necroptosis Signaling
by: Hong Hu, et al.
Published: (2020-10-01) -
The RIP1-RIP3 Complex Mediates Osteocyte Necroptosis after Ovariectomy in Rats.
by: Hongwang Cui, et al.
Published: (2016-01-01) -
Akt Regulates TNFα synthesis downstream of RIP1 kinase activation during necroptosis.
by: Colleen R McNamara, et al.
Published: (2013-01-01)